ÂÜÀòÂÒÂ×

Patrick Fabbio has a strong background in finance, with extensive experience as a Chief Financial Officer (CFO) in various pharmaceutical and biotech companies. Patrick is currently serving as the CFO of Protara Therapeutics since January 2023. Prior to this role, they held the position of CFO at Rafael Holdings Inc. from September 2021 to January 2023. Before that, they served as the CFO of WindMIL Therapeutics from March 2020 to September 2021. Patrick also has experience as a CFO at Progenics Pharmaceuticals, Inc. from November 2015 to March 2020 and electroCore LLC in 2015. Patrick held the role of VP Corporate Finance at NPS Pharmaceuticals from March 2012 to May 2015. Patrick has also served as the VP Finance, Innovation and Growth at Catalent Pharma Solutions from July 2010 to March 2012. Additionally, they have worked at Ikano Therapeutics Inc. as a CFO in 2009 and held the position of Sr Director, Mature Products and LCM at sanofi-aventis from 2004 to 2009. In 2018, they became a member of the Board of Directors at BeyondSpring. Overall, Patrick Fabbio has a diverse work experience in the pharmaceutical and biotech industry, particularly in financial management and leadership roles.

Patrick Fabbio pursued their education at the NYU Stern School of Business from 1994 to 1996, where they obtained their MBA degree with a focus on finance. Prior to that, they attended Pace University - Lubin School of Business from 1985 to 1989, earning a Bachelor of Science degree in accounting.